CHINA PHARMA HOLDINGS, INC. Debt Instrument, Convertible, Number of Equity Instruments
CHINA PHARMA HOLDINGS, INC. (CPHI) had Debt Instrument, Convertible, Number of Equity Instruments of 35000000.00% as of 2022-04-19, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments · last filed 2023-08-14
- CHINA PHARMA HOLDINGS, INC. debt instrument, convertible, number of equity instruments for the quarter ending 2022-03-31 was 165000000.00%.
- CHINA PHARMA HOLDINGS, INC. debt instrument, convertible, number of equity instruments for fiscal 2021 was 175000000.00%.
| Period end | Debt Instrument, Convertible, Number of Equity Instruments | Debt Instrument, Convertible, Number of Equity Instruments 3 month | Debt Instrument, Convertible, Number of Equity Instruments 12 month |
|---|---|---|---|
| 2022-04-19 | 35000000.00% 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | 165000000.00% 10-Q · filed 2022-05-12 | ||
| 2021-12-31 | 175000000.00% 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |